In this video interview, Dr Eric Jonasch from MD Anderson Cancer Center in Houston, Texas, talks about the introduction of immunotherapy and immunotherapy-targeted therapy combinations over the past two years for the first-line treatment of metastatic renal cell carcinoma (RCC).

Watch the video interview on Practice Update here